Solnatide

N/A

Report date: 2026/05/25 10:37:13
NME

Base Information

Drug NameSolnatide
Drug Alias Name17-mer cyclic peptide (Bcn Peptides)human TIP peptide (Bcn Peptides)TIP-peptideAP-301 (APEPTICO Forschung und Entwicklung GmbH)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionEpithelial sodium channel agonists
TargetsEpithelial sodium channel
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVrije Universiteit BrusselApeptico Forschung Und Entwicklung GmbhThe Barcelona Institute of Science and Technology +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesApeptico Forschung Und Entwicklung Gmbh
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksDrugBank